OrganiGram (NasdaqGS:OGI) Q1 2026 Earnings call February 10, 2026 08:00 AM ET Company ParticipantsGreg Guyatt - CFOJames Yamanaka - CEOMax Schwartz - Director of Investor RelationsPablo Zuanic - Managing DirectorConference Call ParticipantsAaron Grey - Research AnalystBrenna Cunnington - Research AnalystKenric Tyghe - Stock AnalystOperatorI will now hand the call over to Max Schwartz, Director of Investor Relations. Please go ahead.Max SchwartzVery much, Kara. Good morning, everyone. Thanks for joining us t ...

OrganiGram (NasdaqGS:OGI) Q1 2026 Earnings call February 10, 2026 08:00 AM ET Speaker6I will now hand the call over to Max Schwartz, Director of Investor Relations. Please go ahead.Speaker5Very much, Kara. Good morning, everyone. Thanks for joining us today. As a brief reminder, this call is being recorded, and a replay will be available on our website within 24 hours. Today's call will include forward-looking information, forward-looking statements, and actual results could differ materially due to a numbe ...

Organigram Reports First Quarter Fiscal 2026 ResultsFeb 10, 2026 6:00 AM Eastern Standard Time# Organigram Reports First Quarter Fiscal 2026 ResultsShare---Strong year-over-year growth supported by Canadian leadership and growing international sales, improving gross margin.TORONTO--([BUSINESS WIRE])--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company†or "Organigram†), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 ...